A public private partnership will lay the foundation stone of the financing of the AESKU.KIPP INSTITUTE. The activities of the institute will be promoted by the financial support of the initiators of the AIRA e.V., i.e.
Dr. Torsten Matthias, proprietor of AESKU.DIAGNOSTICS and the Swiss private investor Dr. h.c. Karl-Heinz Kipp. In addition, the Economics Department of state of Rhineland-Palatinate granted parts of the equipment AESKU.KIPP INSTITUTE’s laboratory.
The implementation of current research projects into developmental projects involves the increasing cooperation of the AESKU.KIPP INSTITUTE with commercial enterprises, within the limits laid down by the supporting association AIRA e.V.
Dr. Torsten Matthias
Dr. Torsten Matthias, founder and owner of AESKU.DIAGNOSTICS, has extensive experience in research and development. For nearly two decades, his professional work and activities focused on the topic of autoimmunity.
A number of awards are testimony to the highly innovative character of the company and the unique selling points of the products.
- “Pioniergeist 2000”, award from the state of Rhineland-Palatinate for the business concept.
- “Innovation Prize 2001” from the state of Rhineland-Palatinate for the development of the patented alpha-fodrin test.
The clear objective of the research and development work of Dr. Torsten Matthias is, above all, the development of innovative and, at the same time, market-oriented diagnostics and therapies. Alongside the further positive development of the company, Dr. Torsten Matthias is pursuing the objective of attaining the close networking of interdisciplinary research in the fields of the pathogenesis, diagnosis and therapy of autoimmune diseases, and of guaranteeing such a network in the long term.
Dr. h.c. Karl-Heinz Kipp
Dr. h.c. Karl-Heinz Kipp began his extraordinary career as an entrepreneur as long ago as 1948 with the acquisition of the Trier-based national costume shop “Trierer Trachten und Bänderhandlung Alfred Massa”. In 1965, he founded the first Massa consumer market and then rapidly rose through the ranks of the leading self-service stores with unique concepts.
In line with his strong ties to his first business headquarters in Alzey, he invested in the development of the high technology centre MikroForum in Wendelsheim near Alzey.
In 2003, together with the company AESKU.DIAGNOSTICS, Wendelsheim, and in cooperation with the Laura Schwartz- Kipp Foundation established by himself, he supported the creation of the world’s first chair for autoimmunity at the University of Tel Aviv, Israel.
Karl-Heinz Kipp supports the development of the AESKU.KIPP INSTITUTE as a private investor, so as to promote research into autoimmunity, and to open up new development opportunities for the MikroForum and for the Rhineland-Palatinate as a research location.